KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verisign (VRSN) Liabilities and Shareholders Equity (2016 - 2025)

Verisign (VRSN) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $1.4 billion as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Liabilities and Shareholders Equity fell 6.46% year-over-year to $1.4 billion, compared with a TTM value of $2.9 billion through Dec 2025, down 53.2%, and an annual FY2024 reading of $1.4 billion, down 19.58% over the prior year.
  • Liabilities and Shareholders Equity was $1.4 billion for Q2 2025 at Verisign, down from $1.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.0 billion in Q4 2021 and bottomed at $1.4 billion in Q4 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity increased 12.28% in 2021, then fell 19.58% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $2.0 billion in 2021, then decreased by 12.62% to $1.7 billion in 2022, then increased by 0.9% to $1.7 billion in 2023, then decreased by 19.58% to $1.4 billion in 2024, then increased by 0.09% to $1.4 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for VRSN at $1.4 billion in Q2 2025, $1.4 billion in Q1 2025, and $1.4 billion in Q4 2024.